Eczema Foundation

What Eczema Foundation does

The Pierre Fabre Eczema Foundation (Fondation d'Entreprise des Laboratoires Pierre Fabre) is a non-profit corporate foundation headquartered in Toulouse, France, established in 2004 by Pierre Fabre Laboratories. It provides free medical information, patient education, and support resources to eczema patients (children, adults, and infants with atopic dermatitis, contact eczema, and related conditions) and to the dermatology, allergy, general practice, nursing, and pharmacy professionals who treat them. Core digital assets include a Drupal-based multilingual website available in eight languages (French, English, Spanish, Italian, Portuguese, German, Chinese, Arabic) and the Eczema Care+ mobile application on iOS and Android, launched in 2023, which integrates the ETFAD-validated PO-SCORAD severity scoring system with proprietary AI modules (EczemaOBS for real-time treatment analysis and personalized advice; EczemaPRED for weekly trend prediction, co-developed with Imperial College London).

The foundation's product surface also includes a Physician Alert system that flags stagnant or worsening eczema over defined windows and simplifies communication with clinicians, a 24/7 website chatbot (robot conversationnel), and structured in-person education programs delivered through its Atopy Schools (Ecoles de l'Atopie) network in France and French-speaking regions. Marketing and patient acquisition are conducted via organic social channels (LinkedIn, TikTok, Facebook, Instagram, YouTube), a GDPR-compliant email newsletter, and SEO/content marketing through the multilingual site. The organization does not display advertising and does not accept third-party advertising funds.

Commercially, the foundation generates no revenue from users: all services are provided free of charge. Its entire operating budget is funded by founding member Pierre Fabre Laboratories and its dermo-cosmetic brands (Avène, Ducray, A-Derma). The foundation operates as a corporate social responsibility and disease-awareness asset within the Pierre Fabre group rather than as an independent commercial entity, which is also reflected in its parent-subsidiary governance structure (Dr. Georges Farah serves as President and Director of Publication).

Name

Eczema Foundation

Legal name

Pierre Fabre Eczema Foundation

Website

https://pierrefabreeczemafoundation.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The Pierre Fabre Eczema Foundation is a Toulouse-based non-profit corporate foundation that provides free, multilingual eczema education, patient support, and the Eczema Care+ tracking app with AI-powered severity analysis to patients and healthcare professionals worldwide, fully funded by Pierre Fabre Laboratories.

Ownership category

akta.pro rank

Product category

Dermatology Patient Education and Support

NAICS

Educational Support Services (61171)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Psoriasis & Eczema Specialty Care (HLAKACAL)

Keywords

• Patient education platform
• Dermatology non-profit
• Mobile health tracking
• Therapeutic patient education
• Eczema clinical scoring

Headquarters

HQ city

Toulouse

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Foundation Funding: The foundation operates as a non-profit enterprise foundation (Fondation d'Entreprise) fully funded by Pierre Fabre Laboratories. The website does not display advertising and does not accept or receive advertising funds from any other source than its founding members.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

The Pierre Fabre Eczema Foundation provides free, medically-validated patient education, information, and digital self-management tools for eczema (atopic dermatitis and related skin conditions). Its primary digital product is the Eczema CARE+ mobile application (iOS/Android), which combines the ETFAD-validated PO-SCORAD clinical scoring tool with AI algorithms (EczemaOBS for treatment analysis and EczemaPRED for trend prediction) developed in collaboration with Imperial College London. The foundation also operates in-person Atopy Schools (Ecoles de l'Atopie) across France for therapeutic patient education and maintains a multilingual (8-language) content library covering all aspects of eczema diagnosis, treatment, and daily management.

Product overview

The Pierre Fabre Eczema Foundation operates primarily as an information and education platform (website) providing eczema-related medical information, practical advice, a glossary, FAQ, and a directory of eczema specialists (Atopy Schools). Its core branded digital product is the Eczema CARE+ mobile application (iOS/Android), which integrates three interconnected modules: the PO-SCORAD severity scoring engine, the EczemaOBS AI-powered treatment analysis and recommendation module, and the EczemaPRED AI-powered weekly trend prediction module. The foundation website also embeds a 24/7 chatbot (robot conversationnel) for user interaction.

Differentiator

Problem solved

Functional benefit

Products and services

• Eczema CARE+ Mobile Application A free mobile application (iOS/Android) developed by the Pierre Fabre Eczema Foundation to help eczema patients track disease severity using the PO-SCORAD clinical score, visualize eczema evolution, prepare for medical consultations, share data with healthcare professionals, and receive personalized AI-powered insights (EczemaOBS) and weekly trend predictions (EczemaPRED). Designed for eczema patients of all ages and the healthcare professionals who treat them.
• Atopy Schools (Ecoles de l'Atopie) In-person therapeutic patient education workshops conducted in age-appropriate groups by healthcare professionals at hospitals and specialized centers across France. Sessions help patients learn about their disease, optimize treatment, develop self-management skills, and connect with other patients and providers. Free service for eczema patients and families.
• Multilingual Eczema Medical Information Website A free multilingual website providing comprehensive medically-validated information about all types of eczema (atopic, contact, varicose, bullous, dyshidrotic, nummular, infant, child, adult, on dark skin), treatment options, body localizations, practical daily-living advice (anti-scratching tips, bathing, hydration, dermocorticoid application, diet, sun exposure, sports, tattoos, workplace), and a directory of specialized healthcare professionals (Atopy Schools). Available in 8 languages globally.

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Imperial College LondoncoreStrategic or Co-development PartnerCollaboration on the development of the EczemaPRED AI algorithm, an intelligent algorithm that estimates the weekly trend of eczema intensity based on research conducted with Imperial College London. This partnership brings academic research credibility and novel AI capabilities to the foundation's digital tools.
• ETFAD (European Task Force on Atopic Dermatitis)coreStrategic or Co-development PartnerThe foundation's Eczema Care+ application uses the PO-SCORAD (Patient-Oriented SCORAD) clinical scoring system developed and validated by ETFAD, a group of European dermatology experts. This ensures clinical validity and alignment with international medical standards.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Regional players

• Association Française de l'Eczéma: French patient association dedicated to eczema awareness and support. Direct French-market peer in disease-specific patient education and advocacy.
• Fondation de l'Atopique: French foundation focused on atopic dermatitis research and patient support. Direct disease-area peer in the same French non-profit education ecosystem.

Emerging players

• Allergy & Asthma Network: US nonprofit that educates patients and families on allergic conditions including atopic dermatitis. Comparable patient-education and outreach model, though broader across allergy/asthma.
• Miiskin: Commercial mobile app and AI platform for skin tracking, including eczema and mole monitoring. Comparable patient-facing digital dermatology tool, though for-profit and broader in scope.
• SkinVision: AI-driven smartphone dermatology app focused on skin lesion assessment. Comparable AI-augmented skin-tracking mobile experience targeted at consumer patients.
• Dermatica: UK online dermatology service combining clinician review with personalized skincare routines. Comparable digital dermatology patient-journey product, though commercial rather than non-profit.

Direct peers

• National Eczema Association: US-based nonprofit patient-advocacy and education organization focused exclusively on eczema. Operates a multilingual website, patient education programs, and community resources, paralleling the Pierre Fabre Eczema Foundation's role in France/Europe.
• National Eczema Society: UK-based charity providing information, support, and community for people with eczema. Closely comparable mission of medically validated education and patient support for atopic dermatitis.
• Eczema Society of Canada: Canadian patient organization offering eczema education, support resources, and community programs. Comparable non-profit, disease-specific educational and support mission.

Others

• Pierre Fabre Laboratories: Parent corporate sponsor and dermo-cosmetic/pharmaceutical group behind Avène, Ducray, A-Derma. Not a direct peer but the strategic and financial backbone of the foundation, with adjacent atopic skin care products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtiktok.com/@eczemafoundation
• YouTubeyoutube.com/c/PierreFabreEczemaFoundation
• Facebookfacebook.com/EczemaFoundation
• LinkedInlinkedin.com/company/fondationeczema
• Instagraminstagram.com/eczemafoundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eczema Foundation